Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Apply
CLN-049
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step